Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
Open accessThe DOI matches its Crossref record; 64 of the 70 references it cites were found in a registry or an index, and 6 are not checked yet; 19 of the 29 sources its claims cite were checked for support.
Abstract
Another benefit of dietary fiber: The gut microbiome can modulate the immune system and influence the therapeutic response of cancer patients, yet the mechanisms underlying the effects of microbiota are presently unclear. Spencer et al . add to our understanding of how dietary habits affect microbiota and clinical outcomes to immunotherapy. In an observational study, the researchers found that melanoma patients reporting high fiber (prebiotic) consumption had a better response to checkpoint inhibitor immunotherapy compared with those patients reporting a low-fiber diet. The most marked benefit was observed for those patients reporting a combination of high fiber consumption and no use of over-the-counter probiotic supplements. These findings provide early insights as to how diet-related factors may influence the immune response. —PNK
Verified 2026-10-05 · 6 references not checked yet
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 0 Not valid · 3 Not checked · 41 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Gut bacteria modulate the response to immune checkpoint blockade (ICB) treatment in cancer”
§ Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response > Abstract
What the sources say
- Not checked yetcites [2] Routy B, Science 359, 91– 97 (2018). 29097494 source
- Supportedcites [3] Matson V, Science 359, 104– 108 (2018). 29302014 PMC6707353 source
The supplied Abstract passage reports an association between gut microbial composition and clinical response to anti-PD-1 therapy in metastatic melanoma patients. It also reports that transferring responder-associated microbiota improved anti-PD-L1 efficacy in mice, supporting the claim that gut bacteria can modulate response to checkpoint blockade. (LLM, conf=0.91)
- Partly supportedcites [4] Gopalakrishnan V, Science 359, 97– 103 (2018). 29097493 PMC5827966 sourceExperimental — accuracy not yet measured
The paper’s concluding passage says the gut microbiome may modulate responses to anti-PD-1 immunotherapy in melanoma patients. The citing sentence states this more broadly and definitively for immune checkpoint blockade in cancer; the paper’s patient findings are limited to melanoma and anti-PD-1 treatment. Page numbers were not provided in our copy. (LLM, conf=0.85)
- Partly supportedcites [5] Frankel AE, Neoplasia 19, 848– 855 (2017). 28923537 PMC5602478 sourceExperimental — accuracy not yet measured
The Introduction reports that gut microbiota affect checkpoint-therapy responses in preclinical mouse models, and the Results find different bacterial species enriched in melanoma patients who responded to treatment. The human findings are associations, however; the paper says the mechanism of immune enhancement by these bacteria in humans remains unknown. Thus it does not establish that gut bacteria modulate treatment response in cancer patients. (LLM, conf=0.84)
- Supportedcites [6] Peters BA, Genome Med 11, 61 (2019). 31597568 PMC6785875 source
The Conclusions state that the pilot study supports the notion that gut microbiota modulate immunotherapy response in melanoma patients. The Background identifies the treatments studied as PD-1 and CTLA-4 checkpoint inhibitors, matching the claim’s reference to immune checkpoint blockade. (LLM, conf=0.91)
- Partly supportedcites [7] Andrews MC, Nat. Med 27, 1432– 1441 (2021). 34239137 PMC11107795 sourceExperimental — accuracy not yet measured
The Main Text reports that several gut bacterial taxa differed between melanoma patients who did and did not respond to combined checkpoint blockade, with related associations in mouse tumor models (page unavailable). This supports a link between gut bacteria and treatment response, but the patient findings are associations; they do not establish that bacteria modulate response in cancer patients generally. (LLM, conf=0.82)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“given the known impact of these on ICB response (32)”
§ Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response > Abstract
What the sources say
- Partly supportedcites [32] Pinato DJ, JAMA Oncol 5, 1774– 1778 (2019). 31513236 PMC6743060 sourceExperimental — accuracy not yet measured
The Key Points report that antibiotics given within 30 days before immune checkpoint inhibitor therapy were associated with a higher risk of disease refractory to treatment. The claim is broader than the finding: the paper reports an observational association for prior antibiotic use, while its Limitations section says concurrent antibiotic use was not associated with response. (LLM, conf=0.86)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“however, this is not unexpected given the known challenges of isolating associations of specific dietary components from other factors known to affect the gut microbiota in observational human cohorts (33, 34).”
§ Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response > Abstract
What the sources say
- Supportedcites [33] Klurfeld DM, Am. J. Physiol. Endocrinol. Metab 315, E1087– E1097 (2018). 30130151 PMC6415710 source
The WORKSHOP SUMMARY ('Focus on human studies of the colonic microbiome') states numerous challenges in characterizing diet effects on the human gut microbiome, including poor adherence, inaccurate characterization of dietary intake/composition, and that human observational studies generally point only to associations, with logistical challenges in large cohort studies. The same summary notes that diets high in protein or fat are necessarily low in carbohydrates, 'making it almost impossible to attribute causality to an individual macronutrient,' and lists nondietary factors (stress, exercise, smoking, coffee, personality) plus marked interindividual variation that must be recorded. The table under 'Choice of species depends on question(s) asked.' adds that cross-sectional studies cannot prove causality and that intake recording is relatively inaccurate. Together these support the paraphrase that isolating specific dietary components from other microbiota-affecting factors in observational human cohorts is challenging. (LLM, conf=0.87)
- Not checked yetcites [34] Makki K, Deehan EC, Walter J, Bäckhed F, Cell Host Microbe 23, 705– 715 (2018). 29902436 source
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Given that many of the response-associated bacteria identified in our cohort have known roles in starch degradation and fiber fermentation (25–29)”
§ Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response > Abstract
What the sources say
- Supportedcites [25] Flint HJ, Scott KP, Duncan SH, Louis P, Forano E, Gut Microbes 3, 289– 306 (2012). 22572875 PMC3463488 source
The paper’s Firmicutes sections describe starch utilization by Roseburia and Eubacterium rectale and plant-fiber polysaccharide utilization by Roseburia intestinalis and other gut bacteria (page numbers unavailable). The citation supports the bacteria’s known roles; identifying which bacteria were response-associated in the citing authors’ cohort is the citing authors’ own observation. (LLM, conf=0.86)
- Partly supportedcites [26] den Besten G, J. Lipid Res 54, 2325– 2340 (2013). 23821742 PMC3735932 sourceExperimental — accuracy not yet measured
In “The composition of gut microbiota” (page unavailable), the review identifies Bacteroidetes as fermenters of nondigestible carbohydrates, supporting a general role for gut bacteria in fiber fermentation. It does not identify the citing paper’s response-associated bacteria or establish that many of them degrade starch. (LLM, conf=0.84)
- Partly supportedcites [27] Poeker SA, Sci. Rep 8, 4318 (2018). 29531228 PMC5847601 sourceExperimental — accuracy not yet measured
The Results and Discussion describe bacterial responses to dietary fibers and identify taxa involved in fermenting or degrading them, including inulin-degrading Ruminococcaceae and Prevotella fermenting complex polysaccharides. The paper does not establish a role in starch degradation for these bacteria. Which bacteria were identified in the citing authors’ cohort is their own finding, not a finding attributed to this source. (LLM, conf=0.84)
- Partly supportedcites [28] So D, Am. J. Clin. Nutr 107, 965– 983 (2018). 29757343 sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says Bifidobacterium and Lactobacillus utilize prebiotic fibers as substrates and discusses their fermentation preferences, supporting the fiber-fermentation part. The paper does not establish starch-degradation roles for many bacteria; its References list a work on Ruminococcus bromii and resistant-starch degradation, but that does not substantiate the broader claim. (LLM, conf=0.82)
- Supportedcites [29] Desai MS, Cell 167, 1339– 1353. e21 (2016). 27863247 PMC5131798 source
The Results describe testing gut bacteria for growth on dietary-fiber polysaccharides and identifying which bacteria use each carbohydrate. The supplemental figure (Additional information; page unavailable) identifies several species as plant-fiber and starch degraders and depicts short-chain fatty acid production from plant fiber. The cited paper supports those functional roles; the statement that the bacteria were response-associated in the citing authors’ cohort is their own framing. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The observed protective effect of dietary fiber intake in relation to PFS and response remained consistent among the subset of patients treated with anti–PD-1 monotherapy, with the exclusion of patients reporting recent antibiotic use given the known impact of these on ICB response (32) (tables S11 and S12).”
§ Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response > Abstract
What the sources say
- Supportedcites [32] Pinato DJ, JAMA Oncol 5, 1774– 1778 (2019). 31513236 PMC6743060 source
The citation is attached to the rationale for excluding patients with recent antibiotic use, not to the citing authors’ dietary-fiber findings. The Results report that prior antibiotic therapy was associated with poorer response to immune checkpoint inhibitor treatment; the paper distinguishes this from concurrent antibiotic therapy. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
33 more claims · 1 with their cited sources checked
Create a free account to see all 52 claims and to verify the 10 references still open.
- Probably not a substantial claim. 8
- It may state two separate claims as one. 7
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fiber-rich, plant-based diets have the opposite effect, nurturing Bifidobacterium and Lactobacillus, increasing butyrate producers like Roseburia and Eubacterium rectale, and shielding against obesity and insulin resistance via SCFA signaling.15,70,81–83”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Clinical studies have linked deficient SCFA production to conditions such as graft-versus-host disease and poor responses to cancer immunotherapies, spurring interest in SCFA supplementation or diets to restore microbial balance.15,77,88,146,147”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“supporting a potential benefit of microbially produced SCFAs and an adjuvant role of fiber for ICB7,25.”
From Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma (2024) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“First, correlations have been drawn across cancer indications and geographical sites between the taxonomic composition of the gut (and to some degree tumor) microbiota, and ICI responses in patients with melanoma and other cancers.”
From Melanoma and microbiota: Current understanding and future directions (2024) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Second, exposures including medications, especially antibiotics and proton pump inhibitors, and diet that shape the microbiota are associated with ICI responses in patient cohorts and preclinical models.”
From Melanoma and microbiota: Current understanding and future directions (2024) · cites this paper as [13]
Experimental — accuracy not yet measured
28 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Fitting Linear Mixed-Effects Models Using lme4
Bates, D., Mächler, M., Bolker, B., & Walker, S. (2015) · Journal of Statistical Software · doi:10.18637/jss.v067.i01 · Cited by 86,835
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
DADA2: High–resolution sample inference from Illumina amplicon data
Callahan, B. J., McMurdie, P. J., Rosen, M. J., Han, A. W., Johnson, A. J. A., & Holmes, S. P. (2016) · Nature Methods · doi:10.1038/nmeth.3869 · Cited by 35,698
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
The SILVA ribosomal RNA gene database project: improved data processing and web-based tools
Quast, C., Pruesse, E., Yilmaz, P., Gerken, J., Schweer, T., Yarza, P., Peplies, J., & Glöckner, F. O. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1219 · Cited by 33,055
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
lmerTest Package: Tests in Linear Mixed Effects Models
Kuznetsova, A., Brockhoff, P. B., & Christensen, R. H. B. (2017) · Journal of Statistical Software · doi:10.18637/jss.v082.i13 · Cited by 24,346
Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy
Wang, Q., Garrity, G. M., Tiedje, J. M., & Cole, J. R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00062-07 · Cited by 19,885
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
Research works printed but not linked: 1
- H. Mallick A. Rahnavard L. J. McIver S. Ma Y. Zhang L. H. Nguyen T. L. Tickle G. Weingart B. Ren E. H. Schwager S. Chatterjee K. N. Thompson J. E. Wilkinson A. Subramanian Y. Lu L. Waldron J. N. Paulson E. A. Franzosa H. C. Bravo C. Huttenhower Multivariable Association Discovery in Population-scale Meta-omics Studies. bioRxiv 2021.01.20.427420 [Preprint] (2021). .10.1101/2021.01.20.427420 2021.01.20.427420 · doi:10.1101/2021.01.20.427420
Cited by
Items 801–900 of 967
Bacteria beneficially alter the tone of immune responses against tumors
Vitetta, L., & Clarke, S. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.90008-0
Dietary alterations to induce antitumor immunity
Saha, S., & Montrose, D. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.00028-x · Cited by 1
Croisier, E., Brown, T. E., Grigg, A., Chan, P., & Bauer, J. D. (2024) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.13402
Cancer and microbiome-targeted therapies
Meena, A. S., Singh, P., & Shukla, P. K. (2025) · International review of cytology · doi:10.1016/bs.ircmb.2024.12.006 · Cited by 5
Berry Supplement-Modified Human Microbiome Improves Immunotherapy Response in Mouse ModelsPreprint
Jahanbahkshi, S., Bibi, A., Hoyd, R., Dravillas, C. E., Williams, N. F., Zhang, S., Pallerla, A., Suman, S., Amann, J. M., Goruganthu, M., et al. (2025) · medRxiv · doi:10.1101/2025.01.16.25320666
Beyond the Microbiome: The Role of the Metabolome and Diet in Antitumor Immunity
Dizman, N., Robert, M., & McQuade, J. L. (2024) · European Urology Focus · doi:10.1016/j.euf.2025.01.010
Self-citationThe importance of dietary fibre
Karbanová, M., & Vágnerová, T. (2025) · Medicína pro praxi · doi:10.36290/med.2024.039
Bührer, E., Glassée, N., Kiciński, M., Kennedy, O. J., Blank, C. U., Long, G. V., Atkinson, V. G., Dalle, S., Haydon, A. M., Meshcheryakov, A., et al. (2025) · EJC Skin Cancer · doi:10.1016/j.ejcskn.2025.100727
Brandlmaier, M., & Koelblinger, P. (2025) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.15645_g
Microbiota targets in immune checkpoint therapy: How far are we from clinical application?
Zou, T., Tan, J., Chen, Y., & Jingyuan, F. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003668
Mousa, W. K., Ali, A., Abdelmoteleb, R. W. A., Shami, R. A., Alramadan, N., Moutraji, S. A., & Ghemrawi, R. (2025) · Targeted Cancer Therapy Connect · doi:10.69709/ciconnect.2025.154988
The Role of the Microbiome in Surgical Diseases and Their Management
Thomas, R. M. (2025) · Success in academic surgery · doi:10.1007/978-3-031-83034-1_18
Glenny, E. M., Lin, T., Bandera, V. M., Mirminachi, B., Khumukcham, S. S., Gigic, B., Warby, C. A., Aksonova, O., Coleman, M. F., Carpanese, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.19.660576
Prospect of interdisciplinary research on gut microbiota and colorectal cancer immunotherapy
Lu, Y., Zhang, Z., Chen, L., Xue, P., Zhang, Y., Li, Y., & Guo, H. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104832 · Cited by 1
CAT: a conditional association test for microbiome data using a permutation approach
Shi, Y., Zhang, L., Do, K.-A., Jenq, R. R., & Peterson, C. B. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf326
Self-citationHaedenkamp, T. M., Götz, L., Ansafi, T., Gerken, M., Klinkhammer‐Schalke, M., Fischl, A., Riemenschneider, M. J., Maurer, J., Proescholdt, M. A., Kölbl, O., et al. (2025) · Journal of Neuro-Oncology · doi:10.1007/s11060-025-05137-3 · Cited by 1
Hui, D., Zhu, B., Shiyu, Z., Bin, Z., Zaire, D., Ruihan, G., Shuting, L., Zhou, X., Shunchang, Z., Jian, X., et al. (2025) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2025.151675
Deciphering the Influence of Lifestyle Factors on Immunotherapy Efficacy in Cancer Patients
Jolfayi, A. G., Jafari, A., Rahmani, F., Taghizadeh, N., Mohammadi, S., & Rasaei, N. (2025) · Springer eBooks · doi:10.1007/978-3-032-00775-9_417
Zhao, Y., Naidoo, J., Conroy, M. R., Ferri, J. T., Gills, J. J., Chen, K. Y., White, J. R., Glass, S., Assan, W. O., Peloza, K. E., et al. (2025) · medRxiv · doi:10.1101/2025.10.01.25336378
Laviano, A. (2024) · Precision Nutrition · doi:10.1097/pn9.0000000000000077 · Cited by 1
Tai, R., Chen, Z., Zhao, Y., & Shi, R. (2025) · Scientific Reports · doi:10.1038/s41598-025-31328-z
Ariizumi, H., Shimazui, M., Ogawa, C., Kaneki, M., Saito, N., Mura, E., Suzuki, R., Tsurui, T., Iriguchi, N., Ishiguro, T., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1640603
Newsome, R. C., Gharaibeh, R. Z., Pierce, C. M., da Silva, W. V., Paul, S., Hogue, S., Yu, Q., Antonia, S., Conejo-Garcia, J. R., Robinson, L. A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19445605
Newsome, R. C., Gharaibeh, R. Z., Pierce, C. M., da Silva, W. V., Paul, S., Hogue, S., Yu, Q., Antonia, S., Conejo-Garcia, J. R., Robinson, L. A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19445587
Newsome, R. C., Gharaibeh, R. Z., Pierce, C. M., da Silva, W. V., Paul, S., Hogue, S., Yu, Q., Antonia, S., Conejo-Garcia, J. R., Robinson, L. A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19445584
Tsakmaklis, A., Farowski, F., Zenner, R., Lesker, T. R., Strowig, T., Schlößer, H., Lehmann, J., von Bergwelt-Baildon, M., Mauch, C., Schlaak, M. S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26646451
Then, C., Paillas, S., Moomin, A., Misheva, M., Moir, R., Hay, S. M., Bremner, D. M., Roberts (nee Nellany), K. S., Smith, E. E., Heidari, Z., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25824694
Newsome, R. C., Gharaibeh, R. Z., Pierce, C. M., da Silva, W. V., Paul, S., Hogue, S., Yu, Q., Antonia, S., Conejo-Garcia, J. R., Robinson, L. A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19445596
Newsome, R. C., Gharaibeh, R. Z., Pierce, C. M., da Silva, W. V., Paul, S., Hogue, S., Yu, Q., Antonia, S., Conejo-Garcia, J. R., Robinson, L. A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19445593
Newsome, R. C., Gharaibeh, R. Z., Pierce, C. M., da Silva, W. V., Paul, S., Hogue, S., Yu, Q., Antonia, S., Conejo-Garcia, J. R., Robinson, L. A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19445590
Manipulating gut microbial metabolites for cancer therapy: A metabolism-centric approach
Karne, A. S., Alam, M. I., Tiwari, A., Singh, H., Singh, R. K., & Yadav, A. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33459-7.00003-x
Andrade, F. D. O., Bouker, K. B., Önal, M. Ö., Jin, L., Cruz, I., Helferich, W., Gao, A., Andrade, K., Verma, V., Staley, C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.05.692375
Attar, R., Hamid, A., Dar, L. S., Normakhamatov, N. S., & Farooqı, A. A. (2026) · Experientia supplementum · doi:10.1007/978-3-032-06948-1_9
Vollwert-Ernährung – eine naturheilkundliche Ernährungsweise
Leitzmann, C. (2025) · Springer eBooks · doi:10.1007/978-3-662-68881-6_9
Rahman, M., Kabir, M. H., Mohammad, A., Hettiarachchige, I. K., Ogunbote, O., Pinnock, N., Namani, S., & Namani, S. (2025) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/3287 · Cited by 1
A mediterranean-mimicking diet harnesses gut microbiota–derived 3-IAA to rejuvenate T cellPreprint
Yu, X., Li, W., Feng, H., Li, Z., Zheng, H., Sun, S., Li, J., Li, B., & Wu, Q. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.05.697620
An, Y., Zhang, B., He, Q., Li, Z., Yi, X., Yi, H., & Wang, H. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1714169 · Cited by 1
Boku, S., Sakai, S. A., Sawada, K., Horasawa, S., Yoshikawa, A., Nakamura, Y., Fujisawa, T., Yamashita, R., Satake, H., Komatsu, Y., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-7874624/v1
Yoo, E., & Uchida, A. M. (2026) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.70242
Tissue Injury and Biomaterial Treatment Modulate Tumor Growth and Response to ImmunotherapyPreprint
Ruta, A., Gray-Gaillard, E. F., Garcia, J. A., Huyer, L. D., Mathkour, Y., Cherry, C., Patatanian, M., Mejías, J. C., Maestas, D. R., Krishnan, K., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.02.703323 · Cited by 1
Kankkunen, E., Sunela, K. L., Makkonen, T. M., Jalkanen, K. J., & Mattila, K. (2026) · Acta Oncologica · doi:10.2340/1651-226x.2026.44974
A mediterranean-mimicking diet harnesses gut microbiota–derived 3-IAA to rejuvenate T cellPreprint
Yu, X., Li, W., Feng, H., Li, Z., Zheng, H., Sun, S., Li, J., Li, B., & Wu, Q. (2026) · eLife · doi:10.7554/elife.110468.1
A mediterranean-mimicking diet harnesses gut microbiota–derived 3-IAA to rejuvenate T cellPreprint
Yu, X., Li, W., Feng, H., Li, Z., Zheng, H., Sun, S., Li, J., Li, B., & Wu, Q. (2026) · eLife · doi:10.7554/elife.110468
Li, J., Bu, E., Lian, A., Li, Y., & Tao, C. (2026) · npj Science of Food · doi:10.1038/s41538-026-01105-x · Cited by 2
Liu, Z., Liu, M., Chen, H., Li, S., Zheng, N., Xing, G., Zhang, Y., Xu, J., Li, M., Xiao, C., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07900-0 · Cited by 2
Gut microbiome in integrative oncology
Lacey, J., Stringer, A. M., Cross, C., & Wardill, H. R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-30194-0.00004-7
Integrative approaches to renal cell carcinoma
Rao, S. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-30194-0.00018-7
Integrative approaches to lung cancer
Frenkel, M. A., & Sapire, K. J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-30194-0.00040-0
Olekhnovich, E. I., Strokach, A. A., Kanaeva, V. A., Morozov, M. D., Veselovsky, V. A., Zoruk, P. Y., Ivanov, A. B., Odorskaya, M. V., Koldman, S. D., Koldman, V. A., et al. (2026) · Genes and Cells · doi:10.17816/gc678874
The Role of the Microbiome in Sepsis and the Critically Ill Cancer Patient
Franco, D. M., & Estrada, V. H. N. (2026) · Springer eBooks · doi:10.1007/978-3-319-74698-2_208-1
Halle, Ž. B., Tomašić, V., Bišćanin, A., Čačić, P., Saric, I., Mustapić, S., Stojić, J., Luetić, K., Bekić, D., Paić, M., et al. (2026) · Biomedicines · doi:10.3390/biomedicines14030683
Dietary intervention & immunity: underlying mechanisms and future directions
Zhao, J., Li, X., Liang, Y., Dai, T., Chen, C., Guo, M., Zhao, X., & Xu, L. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.03.026 · Cited by 1
Abedi, A., Moghaddam, M. M., Kachuei, R., & Fooladi, A. A. I. (2026) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-026-01171-5
Mesothelioma: a systemic therapy clinical trials snapshot
Dungey, M. R., Mukhtyar, R. M., Dulloo, S., & Fennell, D. A. (2026) · Trends in cancer · doi:10.1016/j.trecan.2026.03.003 · Cited by 1
Feeding the skin: The emerging role of nutritional intervention in dermatological disorders
Xie, A., Guo, R. R., & Wang, T. (2026) · The Innovation Nutrition · doi:10.59717/j.xinn-nutri.2026.100005
Gut microbiota-related biomarkers in immuno-oncology
Silva, C. A. C. (2023) · theses.fr (ABES) · doi:10.70675/9022496ez0bbbz4f94z9760z4ae0a6ee5e7a
Weitekamp, C. A., Watson, C., Hata, E., Hester, K., Kodavanti, U. P., Lau, C. S., Lehmann, D. M., Miller, C. N., Shaffer, R. M., Soliman, F., et al. (2026) · Food and Chemical Toxicology · doi:10.1016/j.fct.2026.116096
The cancer–microbiome axis: Mechanisms and emerging therapeutic strategies
Walker, M., Schwarzfischer, M., & Scharl, M. M. (2026) · Seminars in Immunopathology · doi:10.1007/s00281-026-01072-1
A “healthy gut state” as the key determinant of immune checkpoint inhibitor efficacy
Sokol, H., Elkrief, A., & Routy, B. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.04.034
Gut microbiome modulates carcinogenesis, immunotherapy efficacy and treatment resistance
Sunny, G., Patnaik, A., & Yadav, R. (2026) · Discover Medicine · doi:10.1007/s44337-026-00593-w
Chi, F., Liu, C.-B., Li, J., Xia, X.-W., Hua, Q.-J., & Wang, W. (2026) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v18.i5.118319
Innovative technologies and future perspectives in tumor microbiomics
He, W., Xing, X., Wang, F., Li, L., Cheng, Y., & Yao, G. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-3202-x
Mao, X., Cao, Y., Li, J., Niu, T., Li, L., Deng, X., Liu, A., Tang, L., Shi, L., Ji, M., et al. (2026) · Current Proteomics · doi:10.1016/j.curpro.2026.100108
Akram, F., Zainab, S., Shabbir, I., & Haq, I. U. (2026) · Folia Microbiologica · doi:10.1007/s12223-026-01515-0
Soh, S., Costescu, F., Najmeh, S., Spicer, J., & Amir, A. (2026) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2026.05.067
Metabolic Crosstalk Between Host and Tumor as a Circuit of Resilience in Cancer Therapy
Wang, J., Wu, H., Wang, T., & Nie, M. (2026) · Cells · doi:10.3390/cells15111008
Paredes, J., Funnell, T., Adintori, P. A., Dai, A., Smith, N., Ramos, R. J. J. F., Kaur, P., Li, Z., Pathak, K., Funes, J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.03.729896
From gut to heart: Probiotics-driven cholesterol metabolism, mechanisms and health benefits
Umapathi, P., Siva, N., Balakrishnan, S., Vincent, S., Govindarajan, R. K., Nagdalian, A. A., Evdokimov, I., Kurchenko, V., Lodygin, A., & Duraisamy, S. (2026) · PharmaNutrition · doi:10.1016/j.phanu.2026.100518
Current therapeutic interventions for immune dysregulation induced by gut microbiota
Khatami, F., Karimian, S., & Mohammadipanah, F. (2026) · European journal of medical research · doi:10.1186/s40001-026-04579-3
Zhang, T., Qian, Q., Zhen, Q., Zhang, J., Sun, Y., Zhang, J., Guo, L., Liu, X., Zou, D., Zhou, B., et al. (2026) · mBio · doi:10.1128/mbio.00374-26 · Cited by 1
Strokach, A. A., Zakharevich, N. V., Агинова, В. В., Grigoryevskaya, Z., Petukhova, Bagirova, N. S., Romanov, M. V., Dyachkova, M. S., Morozov, M. D., Veselovsky, V. A., et al. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2681788 · Cited by 1
朱利明, Xu, J. Q., Niu, D., Zhang, X., & Jin, C. (2026) · Cancer Medicine · doi:10.1002/cam4.72061
Self-citationMcCartney, C., Hajjar, R., & Santos, M. M. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1774501 · Cited by 1
Seilhac, M. D., Verdon, M., Goisnard, L., Duquenoy, A., Corvaïa, N., Plantamura, É., Lapaque, N., Béguet-Crespel, F., Laperrousaz, B., Dore, J. M., et al. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2690686
The role of gut microbiota in cancer development and translational modulation strategies
Bai, X., Kang, X., & Wong, S. H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40306-4.00017-x
The role of microbiome–mucosal barrier interactions in neoplastic diseases
Toth, E., Sipos, A., Mikó, E., Nyerges, P., & Bai, P. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40306-4.00007-7
Improving immunity in patients with cancer through diet: mechanisms and gaps
MacPherson, S., Dhaliwal, E., & Lum, J. J. (2026) · Trends Open · doi:10.1016/j.treopn.2026.05.008
Su, X., Xiang, Y., Zhao, H., Li, O., Zhang, L., & Guo, B. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1839030 · Cited by 1
Olędzki, R., & Kerner, K. (2026) · Biomolecules · doi:10.3390/biom16070930
Andrade, F. D. O., Bouker, K. B., Ozgul-Onal, M., Jin, L., Cruz, I., Helferich, W. G., Gao, A., de Oliveira, K. A., Verma, V., Staley, C. M., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1835466
Gupta, A. K. (2026) · International Journal of Molecular and Immuno Oncology · doi:10.25259/ijmio_8_2026
Davar, D., Zarour, H. M., & Trinchieri, G. (2026) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-026-00916-y
Self-citationFan, Z., Mei, Y., Liu, K., Zhang, Y., & Shi, L. (2026) · Pathology - Research and Practice · doi:10.1016/j.prp.2026.156613
Crosstalk Between Opioids and the Anti-Tumour Immune Checkpoint Axis
Alan, P., & Parat, M. (2026) · Current Oncology · doi:10.3390/curroncol33070411
Mao, G., & Lan, H. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2026-015908
Gouveia, L., Serpa, J., & Mendes, C. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-12166-0_3
Zhang, Y., Wang, S., Chang, S., Li, Y., Dang, Y., & Wang, Z. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1803970 · Cited by 1
Olea, X. D., Beede, K. A., Pereira, G. V., Scott, D. A., Petucci, C. J., Martens, E. C., Rodionov, D., Shah, A. S., Martinez, M. P., Kim, H., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102921 · Cited by 1
Self-citationBenlaïfaoui, M., Richard, C., Hunter, S., Méndez-Salazar, E. O., Kourtian, S., Malo, J., Prifti, D. K., Ponce, M., Khalfi, S., Belkaïd, W., et al. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2699457 · Cited by 3
Aging and the Microbiome: precondition for gastrointestinal carcinogenesis
Wizenty, J., & Sigal, M. (2026) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2026.102122
Zhang, Z., Liang, X., Tian, Y., Li, C., Cao, X., Wang, D., Xie, A., Liu, S. X., Lin, K., Li, Q., et al. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2026-015617
Kuang, G., Qiu, Z., Li, L., Bai, J., Ji, H., & Liu, Y. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1893882
Nutraceuticals in Uro-Oncology: A Structured Expert Review and Precision-Oriented Framework
Erten, F., Kalemoglu, E., Küçük, Ö., & Şahin, K. (2026) · Nutrients · doi:10.3390/nu18152411
Microbiome testing in gastrointestinal cancers: From microbial signatures to clinical translation
Nikitina, D., Morkūnas, E., Šabanas, P., Jonaitis, P., Urbonas, T., Gedgaudiene, G., Gedgaudas, R., Kupčinskienė, K., Macas, A., Simenas, Š., et al. (2026) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2026.102127
Amin, I., Elgebaly, A. S., Mohamed, H. H., Abuelhaded, K., Alam-ElDein, K. M., Ibrahim, A. K., Farag, S. A., Adel, A., Hamdy, M., Elkhawanky, M., et al. (2026) · Clinical & Translational Oncology · doi:10.1007/s12094-026-04500-8
Szabó, B. G., Korózs, D., Bator, M., Jeszenszky, K., Lakatos, Gopcsa, L., Reményi, P., & Sinkó, J. (2026) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.70408
Serna, G., Obón‐Santacana, M., Baraibar, I., Moratalla-Navarro, F., Napoli, S., Ruíz‐Pace, F., Mulet-Margalef, N., Guinó, E., Alonso, L., Boleda, L., et al. (2026) · ESMO Open · doi:10.1016/j.esmoop.2026.108342
Sousa, M. E. S., de Almeida, V. D., Júnior, R. R. D. S., Fernandes, T. A. A. D. M., & de Andrade, M. F. (2026) · Cancer Medicine · doi:10.1002/cam4.72108
The Relationship Between (Endo)cannabinoids, the Microbiome and Melanoma
Javid, F. A., Golčić, M., Harej, A., & Belančić, A. (2026) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70304
Metadata
- Authors
- Spencer, C. N., McQuade, J. L., Gopalakrishnan, V., McCulloch, J. A., Vetizou, M., Cogdill, A. P., Khan, M. A. W., Zhang, X., White, M. G., Peterson, C. B., Wong, M. C., Morad, G., Rodgers, T., Badger, J. H., Helmink, B. A., Andrews, M. C., Rodrigues, R. R., Morgun, A., Kim, Y. S., Roszik, J., Hoffman, K. L., Zheng, J., Zhou, Y., Medik, Y. B., Kahn, L. M., Johnson, S., Hudgens, C. W., Wani, K., Gaudreau, P.-O., Harris, A. L., Jamal, M. A., Baruch, E. N., Perez-Guijarro, E., Day, C.-P., Merlino, G., Pazdrak, B., Lochmann, B. S., Szczepaniak-Sloane, R. A., Arora, R., Anderson, J., Zobniw, C. M., Posada, E., Sirmans, E., Simon, J., Haydu, L. E., Burton, E. M., Wang, L., Dang, M., Clise-Dwyer, K., Schneider, S., Chapman, T., Anang, N.-A. A. S., Duncan, S., Toker, J., Malke, J. C., Glitza, I. C., Amaria, R. N., Tawbi, H. A., Diab, A., Wong, M. K., Patel, S. P., Woodman, S. E., Davies, M. A., Ross, M. I., Gershenwald, J. E., Lee, J. E., Hwu, P., Jensen, V., Samuels, Y., Straussman, R., Ajami, N. J., Nelson, K. C., Nezi, L., Petrosino, J. F., Futreal, P. A., Lazar, A. J., Hu, J., Jenq, R. R., Tetzlaff, M. T., Yan, Y., Garrett, W. S., Huttenhower, C., Sharma, P., Watowich, S. S., Allison, J. P., Cohen, L., Trinchieri, G., Daniel, C. R., & Wargo, J. A.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- National Institutes of Health (US)
- Laboratory of Integrative Cancer Immunology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
- Frederick National Laboratory for Cancer Research (US)
- Oregon State University (US)
- Baylor College of Medicine (US)
- Queen's University (CA)
- The University of Texas Health Science Center at Houston (US)
- Laboratory of Cancer Biology and Genetics, CCR, NCI, NIH, Bethesda, MD 20892, USA.
- Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Harvard University (US)
- Weizmann Institute of Science (IL)
- European Institute of Oncology (IT)
- Columbia University (US)
- University of California, San Francisco (US)
- Broad Institute (US)
- Corresponding author
- Spencer, Christine N.
- McQuade, Jennifer L.
- Gopalakrishnan, Vancheswaran
- McCulloch, John A.
- Cogdill, Alexandria P.
- Cohen, Lorenzo
- Trinchieri, Giorgio
- Daniel, Carrie R.
- Wargo, Jennifer A.
- ORCID
- Spencer, Christine N.
- McQuade, Jennifer L.
- Gopalakrishnan, Vancheswaran
- McCulloch, John A.
- Vetizou, Marie
- Cogdill, Alexandria P.
- Khan, Md A. Wadud
- Zhang, Xiaotao
- White, Michael G.
- Peterson, Christine B.
- Wong, Matthew C.
- Morad, Golnaz
- Rodgers, Theresa
- Badger, Jonathan H.
- Helmink, Beth A.
- Andrews, Miles C.
- Rodrigues, Richard R.
- Morgun, Andrey
- Kim, Young S.
- Roszik, Jason
- Hoffman, Kristi L.
- Zhou, Yifan
- Medik, Yusra B.
- Kahn, Laura M.
- Johnson, Sarah
- Hudgens, Courtney W.
- Wani, Khalida
- Gaudreau, Pierre-Olivier
- Harris, Angela L.
- Jamal, Mohamed A.
- Baruch, Erez N.
- Perez-Guijarro, Eva
- Day, Chi-Ping
- Merlino, Glenn
- Pazdrak, Barbara
- Lochmann, Brooke S.
- Arora, Reetakshi
- Anderson, Jaime
- Zobniw, Chrystia M.
- Simon, Julie
- Haydu, Lauren E.
- Burton, Elizabeth M.
- Wang, Linghua
- Dang, Minghao
- Clise-Dwyer, Karen
- Schneider, Sarah
- Anang, Nana-Ama A. S.
- Toker, Joseph
- Malke, Jared C.
- Glitza, Isabella C.
- Amaria, Rodabe N.
- Tawbi, Hussein A.
- Diab, Adi
- Wong, Michael K.
- Patel, Sapna P.
- Woodman, Scott E.
- Davies, Michael A.
- Ross, Merrick I.
- Gershenwald, Jeffrey E.
- Lee, Jeffrey E.
- Hwu, Patrick
- Jensen, Vanessa
- Samuels, Yardena
- Straussman, Ravid
- Ajami, Nadim J.
- Nelson, Kelly C.
- Nezi, Luigi
- Petrosino, Joseph F.
- Futreal, P. Andrew
- Lazar, Alexander J.
- Hu, Jianhua
- Jenq, Robert R.
- Tetzlaff, Michael T.
- Yan, Yan
- Garrett, Wendy S.
- Huttenhower, Curtis
- Sharma, Padmanee
- Watowich, Stephanie S.
- Allison, James P.
- Cohen, Lorenzo
- Trinchieri, Giorgio
- Daniel, Carrie R.
- Wargo, Jennifer A.
- Venue
- Science
- Published
- 2021-12-24
- Volume
- 374
- Issue
- 6575
- Pages
- 1632-1640
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC8970537
- OpenAlex
- W4200001874
- Cited by
- 966
- References
- 70
- Citations by year
- 2026: 236 · 2025: 216 · 2024: 172 · 2023: 212 · 2022: 130
- FWCI
- 46.90
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Cancer Research UK (27140)
- National Heart, Lung, and Blood Institute (R01HL124112)
- National Cancer Institute (P50CA221703, R01CA219896, F32CA260769, U54CA224070, T32CA009599, R25CA203650, P30CA016672, P30CA013696)
- National Institute of Allergy and Infectious Diseases (R56AI109294, R01AI133822, R01AI143886, R01AI109294)
- National Institute of Environmental Health Sciences (P30ES030285)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- dietary fiber, probiotics, gut microbiota, melanoma, immune checkpoint blockade, anti-PD-1 therapy, treatment response, progression-free survival, fecal microbiota, tumor microenvironment, interferon-gamma, cytotoxic T lymphocytes, low-fiber diet
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Progression-Free Survival, Immune Checkpoint Inhibitors, Animals, Dietary Fiber, Fatty Acids, Volatile, Feces, Female, Humans, Immunotherapy, Male, Melanoma, Melanoma, Experimental, Mice, Inbred C57BL, T-Lymphocytes, Cohort Studies, Probiotics, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.